Rutgers Cancer Institute of New Jersey
The Rutgers Cancer Institute of New Jersey (CINJ) is a cancer treatment and research institution that is a part of Rutgers University and located in New Brunswick, New Jersey. CINJ is one of only 51 Comprehensive Cancer Centers in the nation designated by the National Cancer Institute and the only one in New Jersey located in the heart of New Brunswick.
The Rutgers Cancer Institute of New Jersey is an Institute of Rutgers Biomedical and Health Sciences at Rutgers University and is located adjacent to Robert Wood Johnson University Hospital, which serves as its primary clinical affiliate. CINJ delivers comprehensive cancer care to both adults and children and conducts laboratory, clinical, prevention, and population research. Laboratory research at CINJ is supported by more than $99 million annually in cancer-related research grants. CINJ has over 850 employees and manages more than 120,000 patient visits annually.
Facilities
Recent additions to the facility have tripled the square footage to 225,000 square feet (20,900 m2), and the patient care setting was reconfigured to give it the feel of a much smaller institution. CINJ provides a Resource and Learning Center, where patients and their families can review the latest information on advanced therapies and new clinical trials. CINJ is physically connected by a sky bridge to RWJ University Hospital.
Current Leadership
In January 2017, Steven K. Libutti, MD, FACS became the third permanent Director of CINJ. In October 2017, H. Richard Alexander, MD, FACS, joined Rutgers as the chief surgical officer.[1]
Past Permanent Directors
William N. Hait, MD, PhD 1993-2007
Robert S. DiPaola, MD 2008-2016
References
- "Rutgers Cancer Institute names chief surgical officer". www.healio.com. Retrieved 2018-08-16.